Diprotin A

Diprotin A

SCHEMBL6404766

CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)[C@@H](C)CC

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
XIAP P98170 1/20 0.72
DPP4 P27487 10/20 0.54
DPP8 Q6V1X1 3/20 0.54
FAP Q12884 2/20 0.54
DPP9 Q86TI2 2/20 0.54
DPP7 Q9UHL4 2/20 0.54
POLB P06746 1/20 0.53
L3MBTL1 Q9Y468 2/20 0.44
KMT2A Q03164 1/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diprotin A SCHEMBL17867000 1.00 XIAP (0.72) XIAPDPP4DPP8FAPDPP9
SCHEMBL17867012 0.94 XIAP (0.74) XIAPDPP4DPP8FAPDPP9
SCHEMBL29433188 0.94 XIAP (0.67) XIAPDPP4DPP8FAPDPP9
SCHEMBL17867011 0.94 XIAP (0.74) XIAPDPP4DPP8FAPDPP9
SCHEMBL30069149 0.93 XIAP (0.63) XIAPDPP4DPP8FAPDPP9
SCHEMBL30052704 0.92 XIAP (0.77) XIAPDPP4DPP8FAPDPP9
SCHEMBL30240000 0.90 XIAP (0.61) XIAPDPP4DPP8FAPDPP9
SCHEMBL30695687 0.90 XIAP (0.68) XIAPDPP4DPP8FAPDPP9
SCHEMBL18881167 0.89 XIAP (0.61) XIAPDPP4DPP8FAPDPP9
SCHEMBL20250609 0.89 XIAP (0.58) XIAPDPP4DPP8FAPDPP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2808 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116283702-B Compound with antidiabetic activity and preparation method and application thereof 西南医科大学 2025-06-03 CN claimed
CN-120058836-A Compound with antidiabetic activity and application thereof 西南医科大学 2025-05-30 CN claimed
US-20250127720-A1 IONIZABLE LIPID NANOPARTICLES FOR IN UTERO mRNA DELIVERY Peranteau, William (US) 2025-04-24 US claimed
EP-4427588-A2 COMPOSITIONS FOR HEMOLYSIS AND COAGULATION REGULATION AND STABILIZATION OF EXTRACELLULAR VESICLES Streck LLC (US) 2024-09-11 EP claimed
WO-2024085786-A1 MEDIUM AND DEVICE FOR COLLECTING, STORING AND TRANSPORTING Gra Olga Alekseevna (RU) 2024-04-25 WO claimed
EP-4356731-A1 MEDIUM AND DEVICE FOR COLLECTING, STORING AND TRANSPORTING BIOLOGICAL SAMPLES, AS WELL AS THEIR USE FOR THE STABILIZATION OF EXTRACELLULAR NUCLEIC ACIDS Gra, Olga Alekseevna (RU) 2024-04-24 EP claimed
CN-116725118-A Composition of seabuckthorn seed branched-chain amino acid peptide, preparation method, nutrition powder and application 安徽工程大学 2023-09-12 CN claimed
CN-116283702-A Compound with antidiabetic activity and preparation method and application thereof 西南医科大学 2023-06-23 CN claimed
CN-114213504-B Compound with antidiabetic activity and application thereof 西南医科大学 2023-05-09 CN claimed
CN-115873092-A Antibacterial polypeptide from banded snake, preparation method and application thereof 中国药科大学 2023-03-31 CN claimed
CN-115427051-A Therapeutic agents and conjugates thereof 北京轩义医药科技有限公司 2022-12-02 CN claimed
WO-2022155195-A1 IONIZABLE LIPID NANOPARTICLES FOR IN UTERO MRNA DELIVERY PERANTEAU WILLIAM (US) 2022-07-21 WO claimed
CN-114686551-A Pea protein source DPP-IV inhibitory peptide and screening method thereof 江南大学 2022-07-01 CN claimed
CN-114213504-A Compound with anti-diabetic activity and application thereof 西南医科大学 2022-03-22 CN claimed
EP-3946054-A1 COMPOSITIONS, METHODS AND SYSTEMS FOR PROTEIN CORONA ANALYSIS FROM BIOFLUIDS AND USES THEREOF Seer, Inc. (US) 2022-02-09 EP claimed
CN-116410307-B Neutralizing antibody for neutralizing SARS-CoV-2 in six strains and its application TSINGHUA UNIVERSITY (CN) 2026-05-26 CN disclosed
CN-114080232-B Extracellular vesicles for vaccine delivery Lhasa Sales Co.,Ltd. (CH) 2026-05-26 CN disclosed
US-9944925-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. 2018-04-17 US disclosed
US-20160186168-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2016-06-30 US disclosed
US-20050014732-A1 Combination of an aldosterone receptor antagonist and an anti-diabetic agent PHARMACIA CORPORATION (US) 2005-01-20 US disclosed